9581

    542650

    METROPOLIS

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    METROPOLIS HEALTHCARE LTD Share Price Today

    METROPOLIS HEALTHCARE LTD is currently trading at ₹567, up by ₹6.95 from the previous close. The stock touched an intraday high of ₹570.95 and a low of ₹553.80 during the latest trading session. Over the past one year, METROPOLIS HEALTHCARE LTD has delivered a return of 8.85%, while the stock has gained 4.57% in the last one month.

    METROPOLIS HEALTHCARE LTD performance

    Today’s low Today’s high
    ₹ 553.80 ₹ 570.95
    ₹ 553.85
    52 week low 52 week high
    ₹ 412.25 ₹ 600.00
    ₹ 553.85
    Open Price ₹ 567.00
    Prev. Close ₹ 560.05
    Volume (Shares) 32478.00
    Total traded value ₹ 179.87
    Upper Circuit ₹ 672.05
    Lower Circuit ₹ 448.05
    info

    Investment Returns

    Over 1 Month 4.57% Over 3 Months 22.57% Over 6 Months 16.65% Over 1 Year 8.85%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    METROPOLIS HEALTHCARE LTD fundamentals


    • Market cap (Cr) 11,483.10
    • P/E Ratio (TTM) 72.43
    • Beta 0.42
    • Book Value / share 66.99
    • Return on equity 10.97%
    • EPS (TTM) 7.86
    • Dividend yield 0.91%
    • Net profit/quarter (Cr) 43.24
    info icon alternate text
    • Market cap (Cr) 11,455.10
    • P/E Ratio (TTM) 72.43
    • Beta 0.35
    • Book Value / share 66.99
    • Return on equity 10.97%
    • EPS (TTM) 7.86
    • Dividend yield 0.91%
    • Net profit/quarter (Cr) 43.24
    info icon alternate text

    METROPOLIS HEALTHCARE LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 352.03
    Operating Expense 301.23
    Net Profit 43.24
    Net Profit Margin (%) 12.28
    Earnings Per Share (EPS) 2.09
    EBITDA 98.97
    Effective Tax Rate (%) 27.42
    Particulars DEC 2025 (Values in Cr)
    Revenue 334.71
    Operating Expense 286.66
    Net Profit 32.03
    Net Profit Margin (%) 9.56
    Earnings Per Share (EPS) 6.18
    EBITDA 74.41
    Effective Tax Rate (%) 24.31
    Particulars SEP 2025 (Values in Cr)
    Revenue 355.71
    Operating Expense 296.12
    Net Profit 46.63
    Net Profit Margin (%) 13.10
    Earnings Per Share (EPS) 9.00
    EBITDA 93.88
    Effective Tax Rate (%) 24.93
    Particulars JUN 2025 (Values in Cr)
    Revenue 323.63
    Operating Expense 278.73
    Net Profit 35.58
    Net Profit Margin (%) 10.99
    Earnings Per Share (EPS) 6.87
    EBITDA 79.83
    Effective Tax Rate (%) 25.37
    Particulars MAR 2025 (Values in Cr)
    Revenue 311.69
    Operating Expense 290.87
    Net Profit 23.85
    Net Profit Margin (%) 7.65
    Earnings Per Share (EPS) 4.65
    EBITDA 60.12
    Effective Tax Rate (%) 16.64
    Particulars MAR 2026 (Values in Cr)
    Revenue 1365.47
    Operating Expense 1162.61
    Net Profit 157.48
    Net Profit Margin (%) 11.53
    Earnings Per Share (EPS) 7.62
    EBITDA 346.60
    Effective Tax Rate (%) 25.61
    Particulars MAR 2025 (Values in Cr)
    Revenue 1215.75
    Operating Expense 1071.37
    Net Profit 124.80
    Net Profit Margin (%) 10.26
    Earnings Per Share (EPS) 24.35
    EBITDA 284.57
    Effective Tax Rate (%) 22.96
    Particulars MAR 2024 (Values in Cr)
    Revenue 1103.43
    Operating Expense 958.02
    Net Profit 115.89
    Net Profit Margin (%) 10.50
    Earnings Per Share (EPS) 22.63
    EBITDA 270.48
    Effective Tax Rate (%) 26.37
    Particulars MAR 2023 (Values in Cr)
    Revenue 1066.04
    Operating Expense 908.38
    Net Profit 138.95
    Net Profit Margin (%) 13.03
    Earnings Per Share (EPS) 27.14
    EBITDA 290.59
    Effective Tax Rate (%) 22.35
    Particulars MAR 2022 (Values in Cr)
    Revenue 1157.01
    Operating Expense 917.51
    Net Profit 199.53
    Net Profit Margin (%) 17.24
    Earnings Per Share (EPS) 39.00
    EBITDA 351.41
    Effective Tax Rate (%) 26.51
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 255.41
    ROE % 11.99
    ROCE % 14.96
    Total Debt to Total Equity 0.17
    EBITDA Margin 24.30
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 212.47
    ROE % 12.33
    ROCE % 15.72
    Total Debt to Total Equity 0.22
    EBITDA Margin 24.60
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 192.97
    ROE % 15.30
    ROCE % 17.23
    Total Debt to Total Equity 0.34
    EBITDA Margin 26.87
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 173.18
    ROE % 26.96
    ROCE % 30.24
    Total Debt to Total Equity 0.31
    EBITDA Margin 31.07
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 138.23
    ROE % 29.81
    ROCE % 35.83
    Total Debt to Total Equity 0.15
    EBITDA Margin 30.24
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 238.71
    ROE % 10.97
    ROCE % 13.77
    Total Debt to Total Equity 0.16
    EBITDA Margin 23.83
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 199.79
    ROE % 11.78
    ROCE % 15.02
    Total Debt to Total Equity 0.24
    EBITDA Margin 24.96
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 182.78
    ROE % 15.65
    ROCE % 17.19
    Total Debt to Total Equity 0.36
    EBITDA Margin 27.69
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 164.00
    ROE % 25.78
    ROCE % 29.17
    Total Debt to Total Equity 0.30
    EBITDA Margin 30.80
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 138.69
    ROE % 32.35
    ROCE % 37.13
    Total Debt to Total Equity 0.11
    EBITDA Margin 35.66
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 49.01
    Total Assets 1867.17
    Total Liabilities 1867.17
    Total Equity 1334.63
    Share Outstanding 5
    Price to Book Ratio 6.55
    Return on Assets (%) 7.76
    Return on Capital (%) 10.75
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 71.21
    Total Assets 1555.06
    Total Liabilities 1555.06
    Total Equity 1099.27
    Share Outstanding 5
    Price to Book Ratio 8.64
    Return on Assets (%) 8.21
    Return on Capital (%) 11.63
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 93.19
    Total Assets 1501.60
    Total Liabilities 1501.60
    Total Equity 990.71
    Share Outstanding 5
    Price to Book Ratio 6.83
    Return on Assets (%) 9.51
    Return on Capital (%) 13.36
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 166.93
    Total Assets 1530.29
    Total Liabilities 1530.29
    Total Equity 888.16
    Share Outstanding 5
    Price to Book Ratio 12.42
    Return on Assets (%) 13.99
    Return on Capital (%) 18.68
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 419.69
    Total Assets 1004.41
    Total Liabilities 1004.41
    Total Equity 708.06
    Share Outstanding 5
    Price to Book Ratio 16.16
    Return on Assets (%) 18.22
    Return on Capital (%) 25.86
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 25.52
    Total Assets 1684.90
    Total Liabilities 1684.90
    Total Equity 1244.44
    Share Outstanding 5
    Price to Book Ratio 6.55
    Return on Assets (%) 7.40
    Return on Capital (%) 10.03
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 30.46
    Total Assets 1472.70
    Total Liabilities 1472.70
    Total Equity 1031.18
    Share Outstanding 5
    Price to Book Ratio 8.64
    Return on Assets (%) 7.86
    Return on Capital (%) 11.24
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 42.94
    Total Assets 1434.29
    Total Liabilities 1434.29
    Total Equity 936.01
    Share Outstanding 5
    Price to Book Ratio 6.83
    Return on Assets (%) 9.68
    Return on Capital (%) 13.64
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 115.35
    Total Assets 1458.54
    Total Liabilities 1458.54
    Total Equity 839.20
    Share Outstanding 5
    Price to Book Ratio 12.42
    Return on Assets (%) 13.68
    Return on Capital (%) 18.18
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 335.42
    Total Assets 933.43
    Total Liabilities 933.43
    Total Equity 708.92
    Share Outstanding 5
    Price to Book Ratio 16.16
    Return on Assets (%) 21.16
    Return on Capital (%) 27.87
    Particulars MAR 2025 (Values in Cr)
    Net Income 190.85
    Cash from Operations 306.72
    Cash from Investing -201.05
    Cash from Financing -86.63
    Net change in Cash -24.94
    Free Cash Flow 350.13
    Particulars MAR 2024 (Values in Cr)
    Net Income 174.68
    Cash from Operations 301.45
    Cash from Investing -89.41
    Cash from Financing -181.19
    Net change in Cash -6.54
    Free Cash Flow 365.21
    Particulars MAR 2023 (Values in Cr)
    Net Income 187.50
    Cash from Operations 298.66
    Cash from Investing 46.79
    Cash from Financing -292.32
    Net change in Cash 1.55
    Free Cash Flow 351.30
    Particulars MAR 2022 (Values in Cr)
    Net Income 293.35
    Cash from Operations 335.78
    Cash from Investing -737.57
    Cash from Financing 162.52
    Net change in Cash -321.77
    Free Cash Flow 366.44
    Particulars MAR 2021 (Values in Cr)
    Net Income 244.32
    Cash from Operations 305.86
    Cash from Investing 61.70
    Cash from Financing -32.69
    Net change in Cash 278.03
    Free Cash Flow 334.13
    Particulars MAR 2025 (Values in Cr)
    Net Income 162.02
    Cash from Operations 308.79
    Cash from Investing -196.08
    Cash from Financing -84.49
    Net change in Cash -5.57
    Free Cash Flow 347.32
    Particulars MAR 2024 (Values in Cr)
    Net Income 157.40
    Cash from Operations 296.26
    Cash from Investing -81.00
    Cash from Financing -182.99
    Net change in Cash 5.00
    Free Cash Flow 329.01
    Particulars MAR 2023 (Values in Cr)
    Net Income 178.94
    Cash from Operations 281.76
    Cash from Investing 46.72
    Cash from Financing -287.86
    Net change in Cash -3.40
    Free Cash Flow 288.80
    Particulars MAR 2022 (Values in Cr)
    Net Income 271.54
    Cash from Operations 320.21
    Cash from Investing -738.21
    Cash from Financing 171.97
    Net change in Cash -322.19
    Free Cash Flow 357.15
    Particulars MAR 2021 (Values in Cr)
    Net Income 246.04
    Cash from Operations 249.41
    Cash from Investing 73.53
    Cash from Financing -26.32
    Net change in Cash 249.70
    Free Cash Flow 274.38
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8842.95 65.00 13.42 127148.05 6680.00 8948.10
    FORTIS MALAR HOSPITALS LIMITED 51.15 23.14 2.79 95.86 40.75 76.00
    SHREE PACETRONIX LTD. 139.25 16.62 2.93 52.21 71.00 283.15
    TRANSGENE BIOTEK LTD. 3.08 0.00 2.78 23.34 1.83 5.26
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTERPRISE LT 8842.95 84.69 12.76 127148.05 6680.00 8948.10
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 40.48 0.00 -9.84 30.24 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5971.60 26.72 4.95 6532.93 5010.00 6725.00

    METROPOLIS HEALTHCARE LTD shareholding pattern

    Holding
    4.91%
    48.86%
    10.42%
    35.79%
    1.18%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    METROPOLIS HEALTHCARE LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    553.85 0.81 redarrow
    red-green-graph indicator
    2 Bearish
    14 Bullish
    • 5 Days 558.80
    • 26 Days 541.30
    • 10 Days 551.90
    • 50 Days 527.60
    • 12 Days 550.20
    • 100 Days 509.80
    • 20 Days 544.80
    • 200 Days 497.90
    557.75 PIVOT
    First Support 551.10 First Resistance 566.70 Second Support 542.15 Second Resistance 573.35 Third Support 535.50 Third Resistance 582.30
    RSI 60.45 ADX 13.40 MACD 8.85 Williams % R -20.16 Commodity Channel Index (CCI) 183.64
    Date 2026-07-09 Week 193166.00 Same Day 56219.00 Month 160896.00
    1 Year 0.42 3 Year 0.64
    Over 1 Month
    4.57% down
    Over 1 Year
    8.85% down
    Over 3 Months
    22.57% down
    Over 3 Years
    15.61% down
    Over 6 Months
    16.65% down
    Over 5 Years
    -5.65% down

    METROPOLIS HEALTHCARE LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    19 May 2026 1.0 Interim 2 19 May 2026 Equity shares
    11 Nov 2025 4.0 Interim 1 11 Nov 2025 Equity shares
    17 Nov 2023 4.0 Interim 17 Nov 2023 Equity shares
    23 Feb 2023 8.0 Interim 23 Feb 2023 Equity shares
    21 Feb 2022 8.0 Interim 22 Feb 2022 Equity shares
    17 Feb 2021 8.0 Interim 19 Feb 2021 Equity shares
    13 Feb 2020 8.0 Interim 15 Feb 2020 Equity shares
    Ex-Date Ex-Bonus Ratio
    20 Mar 2026 20 Mar 2026 3:1
    Dividend date Dividend amount Dividend type Record date Instrument type
    19 May 2026 1.0 Interim 2 19 May 2026 Equity shares
    11 Nov 2025 4.0 Interim 1 11 Nov 2025 Equity shares
    17 Nov 2023 4.0 Interim 17 Nov 2023 Equity shares
    23 Feb 2023 8.0 Interim 23 Feb 2023 Equity shares
    21 Feb 2022 8.0 Interim 22 Feb 2022 Equity shares
    17 Feb 2021 8.0 Interim 19 Feb 2021 Equity shares
    13 Feb 2020 8.0 Interim 15 Feb 2020 Equity shares
    Ex-Date Ex-Bonus Ratio
    20 Mar 2026 20 Mar 2026 3:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Metropolis Healthcare Ltd?

    Answer Field

    Metropolis Healthcare Ltd share price is for NSE ₹ 567.00 & for BSE ₹ 566.00 as on Jul 10 2026 03:29 PM.

    What is the Market Cap of Metropolis Healthcare Ltd Share?

    Answer Field

    The market cap of Metropolis Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 10 2026 03:29 PM.

    What is the 52 Week High and Low of Metropolis Healthcare Ltd?

    Answer Field

    The 52 Week High and Low of Metropolis Healthcare Ltd for NSE is ₹ 600.00 and ₹ 412.25 and for BSE is ₹ 599.90 and ₹ 413.00.

    What is 1 year return for Metropolis Healthcare Ltd?

    Answer Field

    The 1 year returns on the stock has been 17.75%.

    What is the P/E Ratio of Metropolis Healthcare Ltd Share?

    Answer Field

    As on Jul 10 2026 03:29 PM the price-to-earnings (PE) ratio for Metropolis Healthcare Ltd share is 72.43.

    What is the PB ratio of Metropolis Healthcare Ltd Share?

    Answer Field

    As on Jul 10 2026 03:29 PM, the price-to-book (PB) ratio for Metropolis Healthcare Ltd share is 66.99.

    How to Buy Metropolis Healthcare Ltd Share?

    Answer Field

    You can trade in Metropolis Healthcare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Metropolis Healthcare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Metropolis Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Metropolis Healthcare Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |